CD4 and diabetes mellitus: In the multivariate analysis (Model 1, Table 5), we observed that a lower risk of DM was associated with higher values of CD4+ cell count and exposure to abacavir, emtricitabine, tenofovir, efavirenz, nevirapine, atazanavir, darunavir.